A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Clinical trial NCT02279433 · COMPLETED
Trial details
- NCT number
- NCT02279433
- Sponsor
- Nuvation Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2019-03-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.